{"ok":true,"trend":{"id":405831,"platform":"news","region":"global","key":"a 25-year-old st. louis vaccine startup filed for bankruptcy. it was backed by ‘everybody’","title":"A 25-Year-Old St. Louis Vaccine Startup Filed for Bankruptcy. It Was Backed by ‘Everybody’","url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPOTNqci1mbHFoaF8yRVY4X3otTkNiMFVxdDBFY3R4Sm1ERXdZQXVFdmFGLW9TVjZ1YnZ2SDMwVmM4LUVnalhBQmdHOUNlcUMzaVhsMzYxRkZXNWJiandSMU5zQnk2elRkZ3pfTU5EUnkzU3N2R1hVblhWU0dVSF9Mcl9tMjl5ZER1NVo0SzlxYU9IeVp6amFSaU5pZXFPYjZHS012aFZibW4yRjJMTmVsT0tn?oc=5","first_seen":"2026-09-29T21:41:55.177619Z","last_seen":"2026-09-30T04:33:12.365675Z","last_rank":15,"peak_rank":4,"last_volume":null,"peak_volume":0,"seen_count":6,"score":45.0,"category_hint":"startups","section":"business","category":"startups","summary":"A St. Louis-based vaccine startup has filed for bankruptcy after roughly 25 years in operation, despite backing from a broad range of prominent investors. The company, described as supported by 'everybody' in the investment community, joins a growing list of biotech firms that burned through funding without bringing a product to market. Observers are pointing to it as a cautionary tale about long, costly vaccine development timelines and investor enthusiasm outpacing scientific results.","why":"The collapse of a well-funded, long-running biotech is being covered as a cautionary tale about vaccine development risk.","tone":"negative","entities":["St. Louis"],"summarized_at":"2026-09-30T03:43:31.340170Z","meta":{"via":"scan","lang":"en","term":"startup","source":"inc.com","published":"Tue, 29 Sep 2026 20:21:56 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"St. Louis Vaccine Startup Backed by Major Investors Files for Bankruptcy","section_name":"Business","category_name":"Startups","timeline":[{"captured_at":"2026-09-29T21:41:55.177619Z","rank":4,"volume":null},{"captured_at":"2026-09-29T23:03:54.769230Z","rank":5,"volume":null},{"captured_at":"2026-09-30T00:26:09.167962Z","rank":8,"volume":null},{"captured_at":"2026-09-30T01:48:08.645403Z","rank":8,"volume":null},{"captured_at":"2026-09-30T03:10:30.799055Z","rank":13,"volume":null},{"captured_at":"2026-09-30T04:33:12.365675Z","rank":15,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPOTNqci1mbHFoaF8yRVY4X3otTkNiMFVxdDBFY3R4Sm1ERXdZQXVFdmFGLW9TVjZ1YnZ2SDMwVmM4LUVnalhBQmdHOUNlcUMzaVhsMzYxRkZXNWJiandSMU5zQnk2elRkZ3pfTU5EUnkzU3N2R1hVblhWU0dVSF9Mcl9tMjl5ZER1NVo0SzlxYU9IeVp6amFSaU5pZXFPYjZHS012aFZibW4yRjJMTmVsT0tn?oc=5","author":"inc.com","title":"A 25-Year-Old St. Louis Vaccine Startup Filed for Bankruptcy. It Was Backed by ‘Everybody’","snippet":null,"posted_at":"2026-09-29T20:21:56Z","likes":null}],"elsewhere":[],"window":"7d"}}